Skip to main content

Want a detailed portfolio tracker?

Performance analysis of China SXT Pharmaceuticals (SXTC)

Annual Return

Over the past 3 years, SXTC has had an average annual return of -60.06%, underperforming the benchmark SPY, which returned +22.45% annual.

Over the past 5 years, SXTC has had an average annual return of -82.00%, underperforming the benchmark SPY, which returned +13.88% annual.

Since Jan 4, 2019, SXTC has had an average annual return of -77.51%, underperforming the benchmark SPY, which returned +17.63% annual.

2025202420232022202120202019
+0%-66.67%-75.00%-95.76%-50.61%-59.90%-85.71%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2025+0%+0%+0%
2024-33.33%+0%-50.00%+0%+0%+0%+0%+0%+0%+0%-66.67%
2023+0%-25.00%-33.33%-16.67%-20.00%+25%-20.00%-50.00%+50%-33.33%+0%+50%-75.00%
2022-66.78%+1.06%+28.42%-23.77%-50.54%-17.39%-15.79%-3.12%-45.16%-23.53%+15.38%-20.00%-95.76%
2021+121.29%-34.07%-4.19%-22.85%-9.06%+12.46%-13.92%-6.25%-11.96%-7.80%-25.60%-8.12%-50.61%
2020+19.59%+8.07%-47.16%-21.41%-10.04%+33.04%-24.73%-24.31%-18.55%+15.73%+6.09%+9.56%-59.90%
2019+23.87%-12.66%+9.83%-23.46%-24.52%-9.13%-31.57%+0%-48.57%-9.52%-22.36%-7.33%-85.71%

Drawdown analysis of China SXT Pharmaceuticals (SXTC)

The maximum drawdown for the SXTC was -100.00%, occurring on Jan 19, 2024. This drawdown has not yet recovered.

The current SXTC drawdown is -100.00%.

Since Jan 4, 2019 SXTC has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-100.00%Jan 9, 20191265Jan 19, 2024OngoingOngoingOngoing